Widespread tau seeding activity at early Braak stages.
Acta Neuropathologica; doi: 10.1007/s00401-016-1644-z.
Microtubule density and landing rate as parameters to analyze tau protein in the MT-kinesin “gliding” assay.
Sensors and Actuators B: Chemical; https://doi.org/10.1016/j.snb.2016.07.082.
Restoring the Processivity of Kinesin Nanomotors.
Advanced Biosystems; https://doi.org/10.1002/adbi.201600034.
Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein.
BioMed Central; 10.1186/s40478-017-0435-7.
Tau Antibody–Targeting Pathological Species Block Neuronal Uptake and Interneuron Propagation of Tau in Vitro.
Science Direct Pathology; http://doi.org/10.1016/j.ajpath.2017.01.022.
Remodeling Tau and Prion Proteins Using Nanochaperons.
Advanced Biosystems; https://doi.org/10.1002/adbi.201700108.
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer’s Disease: Analytical and Diagnostic Characterization.
Journal of Alzheimer’s Disease; DOI: 10.3233/JAD-160448.
Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke.
BMC Neurol.; doi: 10.1186/s12883-017-0945-8.
Abolishing Tau cleavage by caspases at Aspartate421 causes memory/synaptic plasticity deficits and pre-pathological Tau alterations.
Translational Psychiatry; doi: 10.1038/tp.2017.165.
Tau peptides and tau mutant protein aggregation inhibition by cationic polyethyleneimine and polyarginine.
Biopolymers; https://www.ncbi.nlm.nih.gov/pubmed/28456996.